Search details
1.
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
PLoS Med
; 19(10): e1004120, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36260627
Results
1 -
1
de 1
1
Next >
>>